Personalized Medicine – News and Features
News
Clarient Inc. and Health Discovery Corporation Jointly Announce Licensing Agreement
Clarient licenses HDC's Support Vector Machine patent portfolio in the field of peripheral rare cell detection.
News
Myriad Genetics and Abbott Extend Collaboration
Abbott will fund the research and Myriad will use its high-throughput sequencing technologies to analyze samples.
News
Schering-Plough and OMS Announce Agreement for use of OMS Pharmacogenomic Technology
Technology to be used to study MGMT Methylation Status in Glioblastoma Multiforme Brain Cancer Patients.
News
Integragen Completes €8 Million Financing to Progress Genetic Tests
The investment will be used to further develop the Company's genetic tests.
News
Accelrys Launches NanoBiology Initiative
Initiative will bring together industry, government and academic experts to drive nanobiology innovation.
News
IBM Joins Forces with top Cancer Centers
IBM Collaborates with MSKCC, the Molecular Profiling Institute and Sainte-Justine Research Center.
News
DxS Launches Bespoke Consultancy and Training Service
Pharmaceutical and clinical research customers can receive training on pharmacogenomics and personalized medicine.
News
Affibody and NIH to Develop Molecular In Vivo Imaging Agents
Affibody will design and develop engineered Affibody® molecules specific for a receptor protein, HER2.
News
DNAPrint Genomics Acquires Kenna Technologies
Key processes will enable development of personalized medicine or 'theranostics' using test/drug combinations.
News
Invader Pharmacogenetic Assay Helps Determine Proper Dosage of Camptosar®
Third Wave and Genzyme Genetics announce preferred marketing relationship for colorectal cancer personalized medicine test
Advertisement
